Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigating the effect of ketamine on psychosomatic pain
IRCT20090801002266N20Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine in somatic symptom disorder (SSD), sponsored by Isfahan University of Medical Sciences. Started Jul 2024; status: completed.
02
Drugs
ketamine
03
Conditions
somatic symptom disorder (SSD)
Beyond the preview
Go deeper on IRCT20090801002266N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090801002266N20.